We read with interest the article by Massoumi et al. (1) regarding 5 patients who developed coronavirus disease 2019 (COVID-19) in the early postoperative period of liver transplantation (LT). None of them exhibited severe disease, and they all fully recovered, suggesting that COVID-19 in the early postoperative period of LT might not be associated with unfavorable outcomes. Here, we share our experience with 7 cases that was not so promising. Between March 24 and July 1, 2020, we performed 28 deceased donor LTs, and 7 patients were diagnosed with COVID-19 in the early posttransplant period, ranging from 9 to 39 days (Table 1). Because there is no clear definition for early COVID-19 after LT, we assumed it to be until postoperative day (POD) 60, irrespective of whether the patient had been discharged home or remained hospitalized.Unlike the series by Massoumi et al., (1) we experienced 3 cases of severe disease (patients 1, 2, and 7), with 2 deaths related to COVID-19. This difference

No abstract

No abstract

HighlightsA complex pancreatic trauma successfully managed with surgical approaches at three different times.Performance of three different times treatment for a complex pancreatic trauma.Proposal of management of complex pancreatic trauma in clinically unstable patients.

Despite the great number of cases of COVID‐19 around the world, data in liver transplant (LT) recipients are still settling down. We share our experience after the first four cases of long‐term LT recipients admitted for hospitalization and the measures for suspicion and diagnostic investigation adopted after these cases. The mean time of initial symptoms at hospitalization was 8 days; only one case had the classical respiratory symptoms.